Shared decision making in patients with substance use disorders: A one-year follow-up study

  1. Serrano-Pérez, Pedro 2
  2. Rivero-Santana, Amado 3
  3. Daigre-Blanco, Constanza 1
  4. Palma-Álvarez, Raúl Felipe 1
  5. Nistal-Franco, Icía 2
  6. Antoni Ramos-Quiroga, Josep 1
  7. Grau-López, Lara 4
  1. 1 Hosp Univ Vall dHebron, Dept Psychiat, Addict & Dual Diag Sect, Barcelona, Spain
  2. 2 Hosp Alvaro Cunqueiro, Dept Psychiat, SERGAS, Vigo, Spain
  3. 3 Canary Isl Hlth Res Inst Fdn FIISC, El Rosario, Spain
  4. 4 Autonomous Univ Barcelona, Dept Psychiat & Forens Med, Barcelona, Spain
Mostrar afiliaciones +
Revista:
Psychiatry Research

ISSN: 0165-1781

Año de publicación: 2023

Volumen: 329

Páginas: 115540

Tipo: Artículo

DOI: 10.1016/J.PSYCHRES.2023.115540 GOOGLE SCHOLAR lock_openAcceso abierto editor

Otras publicaciones en: Psychiatry Research

Referencias bibliográficas

  • Adamson, (2005), Drug Alcohol Rev., 24, pp. 209, 10.1080/09595230500167502
  • Alavi, (2011), Addict. Health, 3, pp. 119
  • Alves, (2017), Drug Alcohol Depend., 179, pp. 299, 10.1016/j.drugalcdep.2017.05.049
  • Aubree Shay, (2015), Med. Decis. Making, 35, pp. 114, 10.1177/0272989X14551638
  • Austin, (2017), Stat. Methods Med. Res., 26, pp. 796, 10.1177/0962280214558972
  • Barrio, (2017), Int. J. Behav. Med., 24, pp. 722, 10.1007/s12529-017-9643-6
  • Bobes, J., Bascarán, T., Bobes-Bascarán, T., Carballo, J.L., Ma, E., Mesa, D., Flórez, G., García-Portilla, P., & Sáiz, P.A. (2017).Valoración de la gravedad de la adicción: Aplicación a la gestión clínica y monitorización de los tratamientos, ISBN: 978-84-611-7641-0.
  • Brener, (2009), Drug Alcohol Depend., 105, pp. 172, 10.1016/j.drugalcdep.2009.06.016
  • Brown, (2002), Addict. Behav., 27, pp. 585, 10.1016/S0306-4603(01)00195-2
  • Charles, (1999), Soc. Sci. Med., 49, pp. 651, 10.1016/S0277-9536(99)00145-8
  • Cuschieri, (2019), Saudi J. Anaesth., 13, pp. S31, 10.4103/sja.SJA_543_18
  • Daigre, (2021), Addict. Behav., 117, 10.1016/j.addbeh.2021.106832
  • Davis, (2020), Substance Abuse, 41, pp. 216, 10.1080/08897077.2019.1671940
  • De Las Cuevas, (2020), Int. J. Clin. Health Psychol., 20, pp. 262, 10.1016/j.ijchp.2020.06.004
  • De Las Cuevas, (2016), Patient Prefer Adherence, 10, pp. 2351, 10.2147/PPA.S122377
  • De las Cuevas, (2014), Patient Educ. Couns., 96, pp. 222, 10.1016/j.pec.2014.05.009
  • De las Cuevas, (2015), Health Expect, 18, pp. 2143, 10.1111/hex.12183
  • Degner, (1997), Can. J. Nurs. Res., 29, pp. 21
  • First, M.B., & Gibbon, M. (2004). The Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-I) and the Structured Clinical Interview for DSM-IV Axis II Disorders (SCID-II). En Comprehensive handbook of Psychological assessment, Vol. 2: Personality assessment (pp. 134–143). John Wiley & Sons, Inc.
  • Friedmann, (2004), Addiction, 99, pp. 962, 10.1111/j.1360-0443.2004.00772.x
  • Friedrichs, (2018), Addict. Behav., 84, pp. 248, 10.1016/j.addbeh.2018.05.002
  • Friedrichs, (2016), PLoS One, 11, 10.1371/journal.pone.0145817
  • Gomà-i-Freixanet, (2008), Psychol. Rep., 103, pp. 845, 10.2466/PR0.103.7.845-856
  • Grau-López, (2012), Adicciones, 24, pp. 115, 10.20882/adicciones.103
  • Green, (2010), Adm. Policy Ment. Health, 37, pp. 327, 10.1007/s10488-009-0239-6
  • Hamann, (2007), Health Expect., 10, pp. 358, 10.1111/j.1369-7625.2007.00458.x
  • Hodgins, (1997), Addict. Behav., 22, pp. 247, 10.1016/S0306-4603(96)00013-5
  • Hser, (1999), J. Subst. Abuse Treat., 16, pp. 299, 10.1016/S0740-5472(98)00037-3
  • Joosten, (2009), Psychother. Psychosom., 78, pp. 245, 10.1159/000219524
  • Joosten, (2011), Subst. Use Misuse, 46, pp. 1037, 10.3109/10826084.2011.552931
  • Knobel, (2002), AIDS, 16, pp. 605, 10.1097/00002030-200203080-00012
  • Kokkevi, (1995), Eur. Addict. Res., 1, pp. 208, 10.1159/000259089
  • Kriston, (2010), Patient Educ. Couns., 80, pp. 94, 10.1016/j.pec.2009.09.034
  • Luty, (2004), Ment. Hosp., 28, pp. 47
  • Lynch, (2021), Subst. Abuse Treat. Prev. Policy, 16, 10.1186/s13011-021-00342-5
  • Marchand, (2019), Subst. Abuse Treat. Prev. Policy, 14, pp. 37, 10.1186/s13011-019-0227-0
  • Marlowe, (2003), Addict. Behav., 28, pp. 387, 10.1016/S0306-4603(01)00248-9
  • Mead, (2000), Soc. Sci. Med., 51, pp. 1087, 10.1016/S0277-9536(00)00098-8
  • Messas, (2019), Psychopathology, pp. 1
  • Montori, (2013), JAMA, 310, pp. 2503, 10.1001/jama.2013.281422
  • Moreno-Chico, (2017), Fam. Pract., 34, pp. 627, 10.1093/fampra/cmx022
  • Mundal, (2021), BMC Psychiatry, 21, pp. 133, 10.1186/s12888-021-03137-x
  • Muthulingam, (2019), J. Subst. Abuse Treat., 100, pp. 18, 10.1016/j.jsat.2019.01.019
  • Neumann, (2006), J. Trauma, 61, pp. 805, 10.1097/01.ta.0000196399.29893.52
  • Neuner, (2007), J. Int. Med. Res., 35, pp. 609, 10.1177/147323000703500505
  • Newland, (2021), J. Health Psychol., 26, pp. 103, 10.1177/1359105320947790
  • Palma-Álvarez, (2021), Addict. Behav., 113, 10.1016/j.addbeh.2020.106681
  • Pirie, (2015)
  • Rodriguez, (2019), Milbank Q., 97, pp. 692, 10.1111/1468-0009.12400
  • Roncero, (2019), Actas Esp. Psiquiatr., 47, pp. 37
  • Ros-Cucurull, (2018), Psychiatry Res., 261, pp. 361, 10.1016/j.psychres.2017.12.069
  • Saheb Kashaf, (2017), Patient Educ. Couns., 100, pp. 2159, 10.1016/j.pec.2017.06.030
  • Schwartz, (2017), Addiction, 112, pp. 454, 10.1111/add.13622
  • Sobell, (1992), Behav. Thera., 23, pp. 43, 10.1016/S0005-7894(05)80307-7
  • Sterling, (1997), Am. J. Addict., 6, pp. 168
  • Vilagut, (2005), Gac. Sanit., 19, pp. 135, 10.1157/13074369
  • Ware, (1992), Med. Care, 30, pp. 473, 10.1097/00005650-199206000-00002
  • (2013), JAMA, 310, pp. 2191, 10.1001/jama.2013.281053
  • Yennurajalingam, (2018), Palliat. Med., 32, pp. 870, 10.1177/0269216317747442
  • Yun, (2019), Int. J. Nurs. Stud., 93, pp. 74, 10.1016/j.ijnurstu.2019.02.012